A study evaluating effect of antibodies to JNJ63823539 on pharmacokinetics of JNJ63823539 in healthy subjects.
Latest Information Update: 07 Apr 2017
At a glance
- Drugs JNJ-63823539 (Primary) ; JNJ-63823539 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Apr 2017 New trial record
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics